Is C-ERB B-2 a predictor for recurrent disease in early stage breast cancer?
- 15 January 1994
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 28 (2) , 395-403
- https://doi.org/10.1016/0360-3016(94)90063-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasiaCancer, 1991
- The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancerBritish Journal of Cancer, 1991
- c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesBritish Journal of Cancer, 1991
- Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancerAnnals of Oncology, 1991
- Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.Journal of Clinical Oncology, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenNature, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958